(Q48587894)

English

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

Results of phase I study of a multi-modality treatment for newly diagnosed glioblastoma multiforme using local implantation of concurrent BCNU wafers and permanent I-125 seeds followed by fractionated radiation and temozolomide chemotherapy. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Christopher M McPherson

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

Margie Gerena-Lewis

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

John C Breneman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

Ronald E Warnick

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

108

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

521-525

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

https://scigraph.springernature.com/pub.10.1007/s11060-012-0854-z

0 references

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Assumptions in the radiotherapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Permanent iodine-125 interstitial implants for the treatment of recurrent glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protoco

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0854-Z

21 January 2018

Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models

1 reference

https://pubmed.ncbi.nlm.nih.gov/22467191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22467191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/22467191

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-012-0854-Z

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/22467191

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48587894&oldid=1534861704"